The effects of C215Fab-SEA monotherapy were further enhanced when combined with anti-PD-1, which resulted in significantly improved tumor growth inhibition and higher rates of tumor-free mice (Fig. 1B, C, Additional file 2: Fig. 2B, C). The gene discussed is PDCD1; the disease is neoplasm.